Literature DB >> 11810081

Polycystic ovary syndrome: a risk for coronary artery disease?

Robert A Wild1.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the literature that was pertinent to cardiovascular risk in women with the polycystic ovary syndrome. STUDY
DESIGN: Medline, Current Contents, and Pub-Med were searched for human studies from the time of our original interest in this issue in 1975 to the present. Only pivotal articles are presented because of page constraints and reference number limits.
RESULTS: Current literature supports the fact that women with this syndrome have risk factors for premature cardiovascular disease.
CONCLUSION: Large multisite cooperative studies are necessary to evaluate cardiovascular morbidity and mortality rates from this syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 11810081     DOI: 10.1067/mob.2002.119180

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

2.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.

Authors:  Andrew J Krentz; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

Review 3.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

4.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

Review 5.  Diagnostic criteria for polycystic ovarian syndrome.

Authors:  F J Broekmans; B C J M Fauser
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 6.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 7.  Menstrual health and the metabolic syndrome in adolescents.

Authors:  Hala Tfayli; Silva Arslanian
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome.

Authors:  A Michael Wallace; Naveed Sattar
Journal:  Clin Biochem Rev       Date:  2007-08

9.  Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Authors:  Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

10.  Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.

Authors:  Eloise Fraison; Elena Kostova; Lisa J Moran; Sophia Bilal; Carolyn C Ee; Christos Venetis; Michael F Costello
Journal:  Cochrane Database Syst Rev       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.